Genmab
A Senior Analytical Specialist in Late Stage Manufacturing Development at Genmab contributes to preparing CMC packages for regulatory filings by focusing on analytical methods for small molecules and peptides. The role supports late-stage product characterization and analytics, working across project teams, partnered CMOs, and internal laboratories. Based in Copenhagen, the position is hybrid and contributes to regulatory submission readiness for antibody and related therapeutic programs.
Headquarters
Valby, Hovedstaden, Denmark
Company Size
1001-5000 employees
Founded
1999
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genmab.
Genmab didn’t post a salary, so this is our estimate from similar listings.
Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Process Development Senior Scientist
Amgen
Manager, CMC Documentation
Bristol Myers Squibb
Mgr/Sr Regulatory CMC Consultant - Small Molecule & Veeva RIM Must Have
Syneos Health
Associate Director, Quality Assurance CMC
Seaport Therapeutics
Director CMC Regulatory Affairs
Recursion
Executive Director, Global CMC Lead
Revolution Medicines